SomnoMed Co-CEO Steps Down; Fiscal 2026 Revenue Misses Guidance

MT Newswires Live

Jul 28

SomnoMed (ASX:SOM) said Co-Chief Executive Amrita Blickstead stepped down, effective Monday, leaving former Co-CEO Karen Borg to assume the role of sole CEO and lead the company's global operations, according to a same-day Australian bourse filing after market hours.

The company has also promoted Chief Transformation Officer Greg Knight to the role of chief operating officer, per the filing.

The company reported preliminary unaudited fiscal 2026 revenue of AU$114 million to AU$115 million, falling short of its AU$119 million to AU$126 million guidance range, while earnings before interest, taxes, depreciation, and amortization (EBITDA) is expected to land near the midpoint of its guided AU$10 million to AU$12 million range.

The revenue shortfall was driven by weaker market conditions in Europe, changes in reimbursement policies and patient referral pathways, as well as the strengthening of the Australian dollar, the filing said.

The company has also initiated a controlled market rollout of its new Virtus oral appliance, designed for obstructive sleep apnea patients who also experience sleep bruxism.

The company expects high single-digit revenue growth in fiscal 2027 while maintaining EBITDA margins at levels consistent with fiscal 2026, the filing added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2654257730"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2654257730\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2654257730?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 06:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2654257730","market":"nz","top_or_hot":-1,"title":"SomnoMed Co-CEO Steps Down; Fiscal 2026 Revenue Misses Guidance","media":"MT Newswires Live","content":"<html><body><p> SomnoMed (ASX:SOM) said Co-Chief Executive Amrita Blickstead stepped down, effective Monday, leaving former Co-CEO Karen Borg to assume the role of sole CEO and lead the company's global operations, according to a same-day Australian bourse filing after market hours.</p><p>The company has also promoted Chief Transformation Officer Greg Knight to the role of chief operating officer, per the filing.</p><p>The company reported preliminary unaudited fiscal 2026 revenue of AU$114 million to AU$115 million, falling short of its AU$119 million to AU$126 million guidance range, while earnings before interest, taxes, depreciation, and amortization (EBITDA) is expected to land near the midpoint of its guided AU$10 million to AU$12 million range.</p><p>The revenue shortfall was driven by weaker market conditions in Europe, changes in reimbursement policies and patient referral pathways, as well as the strengthening of the Australian dollar, the filing said.</p><p>The company has also initiated a controlled market rollout of its new Virtus oral appliance, designed for obstructive sleep apnea patients who also experience sleep bruxism.</p><p>The company expects high single-digit revenue growth in fiscal 2027 while maintaining EBITDA margins at levels consistent with fiscal 2026, the filing added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SomnoMed Co-CEO Steps Down; Fiscal 2026 Revenue Misses Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSomnoMed Co-CEO Steps Down; Fiscal 2026 Revenue Misses Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-28 06:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> SomnoMed (ASX:SOM) said Co-Chief Executive Amrita Blickstead stepped down, effective Monday, leaving former Co-CEO Karen Borg to assume the role of sole CEO and lead the company's global operations, according to a same-day Australian bourse filing after market hours.</p><p>The company has also promoted Chief Transformation Officer Greg Knight to the role of chief operating officer, per the filing.</p><p>The company reported preliminary unaudited fiscal 2026 revenue of AU$114 million to AU$115 million, falling short of its AU$119 million to AU$126 million guidance range, while earnings before interest, taxes, depreciation, and amortization (EBITDA) is expected to land near the midpoint of its guided AU$10 million to AU$12 million range.</p><p>The revenue shortfall was driven by weaker market conditions in Europe, changes in reimbursement policies and patient referral pathways, as well as the strengthening of the Australian dollar, the filing said.</p><p>The company has also initiated a controlled market rollout of its new Virtus oral appliance, designed for obstructive sleep apnea patients who also experience sleep bruxism.</p><p>The company expects high single-digit revenue growth in fiscal 2027 while maintaining EBITDA margins at levels consistent with fiscal 2026, the filing added.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7007","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2654257730","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2654257730","pubTimestamp":1785189736,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"SomnoMed  said Co-Chief Executive Amrita Blickstead stepped down, effective Monday, leaving former Co-CEO Karen Borg to assume the role of sole CEO and lead the company's global operations, according to a same-day Australian bourse filing after market hours.The company has also promoted Chief Transformation Officer Greg Knight to the role of chief operating officer, per the filing.The company reported preliminary unaudited fiscal 2026 revenue of AU$114 million to AU$115 million, falling short of its AU$119 million to AU$126 million guidance range, while earnings before interest, taxes, depreciation, and amortization  is expected to land near the midpoint of its guided AU$10 million to AU$12 million range.The revenue shortfall was driven by weaker market conditions in Europe, changes in reimbursement policies and patient referral pathways, as well as the strengthening of the Australian dollar, the filing said.The company has also initiated a controlled market rollout of its new Virtus o","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7007":"医疗保健设备","SOM.AU":"SOMNOMED LTD"},"translate_title":"SomnoMed 联合首席执行官辞职；2026 财年收入未达到指导","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SOM.AU":1},"content_text":"SomnoMed (ASX:SOM) said Co-Chief Executive Amrita Blickstead stepped down, effective Monday, leaving former Co-CEO Karen Borg to assume the role of sole CEO and lead the company's global operations, according to a same-day Australian bourse filing after market hours.The company has also promoted Chief Transformation Officer Greg Knight to the role of chief operating officer, per the filing.The company reported preliminary unaudited fiscal 2026 revenue of AU$114 million to AU$115 million, falling short of its AU$119 million to AU$126 million guidance range, while earnings before interest, taxes, depreciation, and amortization (EBITDA) is expected to land near the midpoint of its guided AU$10 million to AU$12 million range.The revenue shortfall was driven by weaker market conditions in Europe, changes in reimbursement policies and patient referral pathways, as well as the strengthening of the Australian dollar, the filing said.The company has also initiated a controlled market rollout of its new Virtus oral appliance, designed for obstructive sleep apnea patients who also experience sleep bruxism.The company expects high single-digit revenue growth in fiscal 2027 while maintaining EBITDA margins at levels consistent with fiscal 2026, the filing added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"executive,dataReport,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}